Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of ION-827359 in Participants With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis (CB) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety, tolerability, and efficacy of ION-827359 in mild to moderate COPD with chronic bronchitis; study terminated with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ION-827359

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Chronic Bronchitis, Chronic Obstructive Pulmonary Disease | Phase 2 | Status: TERMINATED | Results posted: 2022-12-20